Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding

The diagnosis of hereditary hemorrhagic telangiectasia (HHT) is based on the Curaçao criteria: epistaxis, telangiectases, arteriovenous malformations in internal organs, and family history. Genetically speaking, more than 90% of HHT patients show mutations in ENG or ACVRL1/ALK1 genes, both belonging...

Descripción completa

Detalles Bibliográficos
Autores principales: Albiñana, Virginia, Cuesta, Angel M., de Rojas-P, Isabel, Gallardo-Vara, Eunate, Recio-Poveda, Lucía, Bernabéu, Carmelo, Botella, Luisa María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356836/
https://www.ncbi.nlm.nih.gov/pubmed/32517280
http://dx.doi.org/10.3390/jcm9061766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356836/
https://www.ncbi.nlm.nih.gov/pubmed/32517280
http://dx.doi.org/10.3390/jcm9061766

Ejemplares similares